MINDBODY Acquires Bowtie.ai

SAN LUIS OBISPO, Calif., May 7, 2019 /PRNewswire/ — MINDBODY, the leading technology platform for the wellness industry, today announced the acquisition of Bowtie.ai (Bowtie), an automated AI-driven virtual receptionist solution for appointment-based businesses. Bowtie automatically books clients, answers questions and enables live chat over SMS and web.

“Bringing Bowtie into the fold fast tracks our delivery of an intelligent, unified messaging experience across all of our platforms,” said Rick Stollmeyer, MINDBODY CEO and co-founder. “Their current solution delivers a powerful conversation management tool to our customers that helps them simplify and grow. And we have much more planned for the future.”

A MINDBODY platform partner since 2017, Bowtie is uniquely focused on AI that directly generates revenue for a business.  Its AI features include, instant text backs for clients who call but are unable to connect with the business, AI messaging over SMS and Webchat for automated bookings and a communication portal to message and track customers across channels. Businesses manage the AI capabilities through a unified dashboard and app.

“The acquisition makes sense on a lot of different levels, but the defining thread from the beginning was to bring our AI technology to small and medium sized businesses, the very same market that has made MINDBODY the dominant software solution in the wellness space,” said Ron Fisher, Bowtie CEO and co-founder. “With MINDBODY, we’ll be able to accelerate what we want to accomplish, which is driving revenue for businesses and providing peace of mind that communication with their clients is always covered.”

The Brooklyn-based start-up was launched three years ago by former Cornell Tech classmates, Fisher (CEO), Mike Wang (CTO) and Vivek Sudarsan (CPO). The Bowtie team has distinguished themselves with cutting edge technology and rapid innovation and will be retained in the acquisition.

About MINDBODY
MINDBODY, Inc. is the leading technology platform for the wellness industry. Local entrepreneurs worldwide use MINDBODY’s integrated software and payments platform to run, market and grow their businesses. Consumers use MINDBODY to more easily find, engage and transact with fitness, wellness and beauty providers in their local communities. For more information on how MINDBODY is helping people lead healthier, happier lives by connecting the world to fitness, beauty and wellness, visit mindbodyonline.com.

© 2019 MINDBODY, Inc. All rights reserved. MINDBODY, FitMetrix, Frederick, the Enso logo, the Booker logo and Connecting the World to Wellness are trademarks or registered trademarks of MINDBODY Inc. in the United States and/or other countries. Other company and product names may be trademarks of the respective companies with which they are associated.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/mindbody-acquires-bowtieai-300845096.html

SOURCE MINDBODY, Inc.

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

4 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

7 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

7 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

7 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

7 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

7 hours ago